| 000 | 01325 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250518062538.0 | ||
| 264 | 0 | _c20200731 | |
| 008 | 202007s 0 0 eng d | ||
| 022 | _a1502-7732 | ||
| 024 | 7 |
_a10.1080/03009742.2019.1657493 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKroon, Fpb | |
| 245 | 0 | 0 |
_aEtanercept therapy leads to reductions in matrix metalloproteinase-3 in patients with erosive hand osteoarthritis. _h[electronic resource] |
| 260 |
_bScandinavian journal of rheumatology _cMar 2020 |
||
| 300 |
_a167-168 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aEtanercept _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHand |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 3 _xblood |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOsteoarthritis _xdrug therapy |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aBay-Jensen, A C | |
| 700 | 1 | _aWittoek, R | |
| 700 | 1 | _aVerbruggen, G | |
| 700 | 1 | _aSmolen, J S | |
| 700 | 1 | _aKloppenburg, M | |
| 700 | 1 | _aRamonda, R | |
| 773 | 0 |
_tScandinavian journal of rheumatology _gvol. 49 _gno. 2 _gp. 167-168 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/03009742.2019.1657493 _zAvailable from publisher's website |
| 999 |
_c30156203 _d30156203 |
||